-The Times of India MUMBAI: Bhavin Dave was married for six weeks when his wife realized she was pregnant. Both rushed to a doctor, who said the best way to deal with the unplanned pregnancy was to use a medical termination of pregnancy (MTP) drug. She prescribed the pills and that was when their ordeal began. Bhavin (name changed) scrambled from pharmacy to pharmacy with the prescription, but to no avail. He...

-The Times of India The government is all set to crack the whip on India's shameful pharma-doctor nexus. The National Development Council (NDC), led by Prime Minister Manmohan Singh, will meet on December 27 to discuss bringing a legislation requiring drug companies to mandatorily disclose payments made to doctors for research, consulting, lectures, travel and entertainment. Doctors involved in ghost writing to promote pharma products will also be disqualified. The official NDC document...

-Oxfam Blog As Oxfam’s two week online debate on the future of agriculture gets under way, John Ambler of Oxfam America imagines how it could all turn out right in the end. It is now 2050.  Globally, we are 9 billion strong.  Only 20% of us are directly involved in agriculture, and poor country economies have diversified.  Yet we all have enough food.  Technological innovation has played its part, but increased production...

-The Wall Street Journal   While modern crop engineering faces endless red tape, more slipshod cross-breeding gets a free pass. India has enjoyed signal successes with genetic engineering in agriculture. But today the nation's relationship with this critical biotechnology is in total disarray, the victim of activists' scaremongering and government pandering. Delhi should know better. Following the adoption of the genetically improved varieties and intensive crop management practices of the Green Revolution, from 1960...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...